Sugiyama Y - Search Results

1

Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver.

Ito K, Iwatsubo T, Kanamitsu S, Ueda K, Suzuki H, Sugiyama Y. Ito K, et al. Among authors: sugiyama y. Pharmacol Rev. 1998 Sep;50(3):387-412. Pharmacol Rev. 1998. PMID: 9755288 Review. No abstract available.

2

Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport.

Ito K, Iwatsubo T, Kanamitsu S, Nakajima Y, Sugiyama Y. Ito K, et al. Among authors: sugiyama y. Annu Rev Pharmacol Toxicol. 1998;38:461-99. doi: 10.1146/annurev.pharmtox.38.1.461. Annu Rev Pharmacol Toxicol. 1998. PMID: 9597163 Review.

3

Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.

Komatsu K, Ito K, Nakajima Y, Kanamitsu Si, Imaoka S, Funae Y, Green CE, Tyson CA, Shimada N, Sugiyama Y. Komatsu K, et al. Among authors: sugiyama y. Drug Metab Dispos. 2000 Apr;28(4):475-81. Drug Metab Dispos. 2000. PMID: 10725317

4

Quantitative prediction of in vivo drug-drug interactions from in vitro data based on physiological pharmacokinetics: use of maximum unbound concentration of inhibitor at the inlet to the liver.

Kanamitsu S, Ito K, Sugiyama Y. Kanamitsu S, et al. Among authors: sugiyama y. Pharm Res. 2000 Mar;17(3):336-43. doi: 10.1023/a:1007509324428. Pharm Res. 2000. PMID: 10801223

5

Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4.

Kanamitsu S, Ito K, Green CE, Tyson CA, Shimada N, Sugiyama Y. Kanamitsu S, et al. Among authors: sugiyama y. Pharm Res. 2000 Apr;17(4):419-26. doi: 10.1023/a:1007572803027. Pharm Res. 2000. PMID: 10870985

6

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.

Iwatsubo T, Hirota N, Ooie T, Suzuki H, Shimada N, Chiba K, Ishizaki T, Green CE, Tyson CA, Sugiyama Y. Iwatsubo T, et al. Among authors: sugiyama y. Pharmacol Ther. 1997;73(2):147-71. doi: 10.1016/s0163-7258(96)00184-2. Pharmacol Ther. 1997. PMID: 9131722 Review.

7

[The role of P-glycoprotein in the liver].

Kusuhara H, Suzuki H, Sugiyama Y. Kusuhara H, et al. Among authors: sugiyama y. Nihon Rinsho. 1997 May;55(5):1069-76. Nihon Rinsho. 1997. PMID: 9155155 Review. Japanese.

8

[Role of transporters in the detoxification of xenobiotics: recent advances in the study of cMOAT/MRP].

Suzuki H, Sugiyama Y. Suzuki H, et al. Among authors: sugiyama y. Tanpakushitsu Kakusan Koso. 1997 Jun;42(8):1273-84. Tanpakushitsu Kakusan Koso. 1997. PMID: 9185476 Review. Japanese. No abstract available.

9

Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes.

Iwatsubo T, Suzuki H, Shimada N, Chiba K, Ishizaki T, Green CE, Tyson CA, Yokoi T, Kamataki T, Sugiyama Y. Iwatsubo T, et al. Among authors: sugiyama y. J Pharmacol Exp Ther. 1997 Aug;282(2):909-19. J Pharmacol Exp Ther. 1997. PMID: 9262358

10

Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data.

Iwatsubo T, Suzuki H, Sugiyama Y. Iwatsubo T, et al. Among authors: sugiyama y. J Pharmacol Exp Ther. 1997 Nov;283(2):462-9. J Pharmacol Exp Ther. 1997. PMID: 9353358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,702 results

Search Page

Filters